Related Experiment Video
Updated: May 25, 2026

Optimizing Tubulin Yield from Porcine Brain Tissue
Published on: October 11, 2024
Discovery of small molecule inhibitors that interact with γ-tubulin
Douglas E Friesen1, Khaled H Barakat, Valentyna Semenchenko
1Department of Oncology, University of Alberta, Edmonton, AB, Canada.
Abstract:
Recent studies have shown an overexpression of γ-tubulin in human glioblastomas and glioblastoma cell lines. As the 2-year survival rate for glioblastoma is very poor, potential benefit exists for discovering novel chemotherapeutic agents that can inhibit γ-tubulin, which is known to form a ring complex that acts as a microtubule nucleation center. We present experimental evidence that colchicine and combretastatin A-4 bind to γ-tubulin, which are to our knowledge the first drug-like compounds known to interact with γ-tubulin. Molecular dynamics simulations and docking studies were used to analyze the hypothesized γ-tubulin binding domain of these compounds. The suitability of the potential binding modes was evaluated and suggests the subsequent rational design of novel targeted inhibitors of γ-tubulin.
Insights
Novel chemotherapy agents targeting gamma-tubulin (γ-tubulin) show promise for glioblastoma treatment. Colchicine and combretastatin A-4 were identified as the first compounds to bind γ-tubulin, a key protein in microtubule nucleation.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Glioblastoma exhibits a poor prognosis, with a low 2-year survival rate.
- Overexpression of gamma-tubulin (γ-tubulin), a microtubule nucleation center, is observed in glioblastomas.
- Targeting γ-tubulin presents a potential therapeutic strategy for glioblastoma.
Purpose of the Study:
- To identify novel chemotherapeutic agents that inhibit γ-tubulin.
- To investigate the interaction of drug-like compounds with γ-tubulin.
Main Methods:
- Experimental binding assays were performed.
- Molecular dynamics simulations were utilized.
- Molecular docking studies were conducted to analyze binding domains.
Main Results:
- Colchicine and combretastatin A-4 were identified as compounds that bind to γ-tubulin.
- These represent the first known drug-like molecules to interact with γ-tubulin.
- Analysis of binding modes suggests potential for rational drug design.
Conclusions:
- Colchicine and combretastatin A-4 show potential as novel inhibitors of γ-tubulin.
- These findings pave the way for the rational design of targeted glioblastoma therapies.
More Related Videos
08:13Spatiotemporal Subcellular Manipulation of the Microtubule Cytoskeleton in the Living Preimplantation Mouse Embryo using Photostatins
Published on: November 30, 2021
10:20Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
Related Concept Videos
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
Destabilization of Microtubules
Microtubule Formation
Microtubule Instability
Microtubule Associated Motor Proteins